Antony W Burgess
Overview
Explore the profile of Antony W Burgess including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
111
Citations
4932
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tan T, Mouradov D, Lee M, Gard G, Hirokawa Y, Li S, et al.
Cell Rep Med
. 2023 Dec;
4(12):101335.
PMID: 38118423
Predictive drug testing of patient-derived tumor organoids (PDTOs) holds promise for personalizing treatment of metastatic colorectal cancer (mCRC), but prospective data are limited to chemotherapy regimens with conflicting results. We...
2.
Wang P, Zhou R, Zhou R, Feng S, Zhao L, Li W, et al.
Redox Biol
. 2023 Dec;
69:102976.
PMID: 38052106
Cold atmospheric plasma (CAP) holds promise as a cancer-specific treatment that selectively kills various types of malignant cells. We used CAP-activated media (PAM) to utilize a range of the generated...
3.
Low R, Fung K, Gao H, Preaudet A, Dagley L, Yousef J, et al.
Cell Death Differ
. 2023 Mar;
30(5):1400.
PMID: 36949280
No abstract available.
4.
Palmieri M, Catimel B, Mouradov D, Sakthianandeswaren A, Kapp E, Ang C, et al.
Mol Cell Proteomics
. 2023 Mar;
22(4):100529.
PMID: 36931626
The canonical view of PI3Kα signaling describes phosphatidylinositol-3,4,5-trisphosphate (PtdIns(3,4,5)P) generation and activation of downstream effectors at the plasma membrane or at microtubule-bound endosomes. Here, we show that colorectal cancer (CRC)...
5.
Faux M, Weinstock J, Gogos S, Prato E, Azimpour A, OKeefe R, et al.
Cancer Res Commun
. 2023 Mar;
2(2):66-77.
PMID: 36860494
Significance: Colorectal cancer is one of the most common cancers worldwide with limited therapeutic options. APC and other Wnt signaling mutations occur in the majority of colorectal cancers but there...
6.
Low R, Fung K, Gao H, Preaudet A, Dagley L, Yousef J, et al.
Cell Death Differ
. 2023 Feb;
30(5):1155-1165.
PMID: 36828915
Epithelial-mesenchymal transition (EMT) is a continuum that includes epithelial, partial EMT, and mesenchymal states, each of which is associated with cancer progression, invasive capabilities, and ultimately, metastasis. We used a...
7.
Burgess A
J Phys Chem B
. 2022 Sep;
126(39):7475-7485.
PMID: 36169380
The epidermal growth factor (EGF) system has allowed chemists, biologists, and clinicians to improve our understanding of cell production and cancer therapy. The discovery of EGF led to the recognition...
8.
Corona S, Walker F, Weinstock J, Lessene G, Faux M, Burgess A
Cancer Med
. 2022 Mar;
11(13):2612-2626.
PMID: 35301819
Introduction: Colorectal cancer (CRC) is driven by a small set of oncogenic and tumour suppressor mutations. However, different combinations of mutations often lead to poor tumour responses to individual anticancer...
9.
Low J, Ho G, Scott M, Tan C, Whitehead L, Barber K, et al.
Cell Death Dis
. 2021 Nov;
12(12):1091.
PMID: 34789734
No abstract available.
10.
Low R, Lim W, Nguyen P, Lee B, Christie M, Burgess A, et al.
Cancers (Basel)
. 2021 Oct;
13(19).
PMID: 34638463
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal solid malignancies. While immortalized cancer cell lines and genetically engineered murine models have increased our understanding of PDAC tumorigenesis, they...